Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC.
Yu HA, Baik C, Kim DW, Johnson ML, Hayashi H, Nishio M, Yang JC, Su WC, Gold KA, Koczywas M, Smit EF, Steuer CE, Felip E, Murakami H, Kim SW, Su X, Sato S, Fan PD, Fujimura M, Tanaka Y, Patel P, Sternberg D, Sellami D, Jänne PA.
Yu HA, et al. Among authors: fujimura m.
Ann Oncol. 2024 Feb 16:S0923-7534(24)00047-4. doi: 10.1016/j.annonc.2024.02.003. Online ahead of print.
Ann Oncol. 2024.
PMID: 38369013